ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

February 28, 2014

In Brief: Coalition Dinner Celebrates NCI’s 50th Anniversary, Honors Lasker, Three Ex-Senators

September 18, 1987

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

New ACS Grants to Fund ‘Critical, Urgent’ Research

April 15, 1977